stockrow
Friday 6 November 2026
Export LFWD’s income statement to Excel — free account
Lifeward Ltd.
LFWD Healthcare Medical Devices
Lifeward Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $22.0 million, down 14.1% from fiscal 2024.
- Revenue
- +15.7%
- EPS
- +40.8%
- Free cash flow
- −52.8%
Quarter to June 2026, against a year earlier
5.87
0.13
+2.26%
Follow LFWD
Alert me
Lifeward Ltd. (LFWD) P/E ratio
Lifeward Ltd. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 0.0× (November 2026) — the current reading is the highest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 42 more quarters | Free account |
Against its own ten years
Low 0.0×
High 0.0×
Ten-year median
0.0×
Current reading's percentile
100
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| NNOX Nano-X Imaging Ltd. compare | n/m |
| CTSO Cytosorbents Corporation compare | n/m |
| ALUR Allurion Technologies, Inc. compare | n/m |
| HSCS HeartSciences Inc. compare | n/m |
| PMI Flag Ship Acquisition Corp compare | n/m |
| RBOT Vicarious Surgical Inc. compare | n/m |
| LFWD Lifeward Ltd. | n/m |
| ARAY Accuray Incorporated compare | n/m |
| SNWV Sanuwave Health Inc. compare | 1.2× |
| Medical Devices industry median | 24.9× |
| Healthcare sector median | 24.5× |
| Market median | 17.8× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)